RxDoctor Payments Data

Thea Davis

Nurse Practitioner · Mesa, AZNPI 1508335159

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,900 of the $13,959 with a category attached, or 85.2%. 29 manufacturers reported payments, led by Amgen at 25.6% of the total. Among nurse practitioner clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,959in general payments, 2019–2025

Across 633 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$4K
  • AbbVie$2K
  • UCB, Inc.$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$742
  • Novartis$738
  • plus $4K from 23 others

What the payments were for

  • Consulting fees$1,67012%
  • Speaking & faculty fees$2802%
  • Food & beverage$11,90085%
  • Education$1091%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,959 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.

See all nurse practitioner providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
XeljanzTofacitinib Citrate54$321,398
Humira(Cf) PenAdalimumab27$279,066
Enbrel SureclickEtanercept28$200,995
Enbrel MiniEtanercept16$118,046
Xeljanz XrTofacitinib Citrate17$95,884
Hydroxychloroquine Sulfate165$7,044
MethotrexateMethotrexate Sodium189$5,210
Leflunomide77$4,359
Sulfasalazine DrSulfasalazine24$1,372
Sulfasalazine41$906
Gabapentin52$769
Prednisone77$723
Diclofenac Sodium20$590
Folic Acid45$504
Tramadol Hcl36$410

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerXeljanz$585$321,39854 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,719 nurse practitioner providers in Arizona.

Other nurse practitioner in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →